Pages that link to "Q44901048"
Jump to navigation
Jump to search
The following pages link to Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo (Q44901048):
Displaying 50 items.
- Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway (Q24304502) (← links)
- Overview of the Pathogenesis of ANCA-Associated Vasculitis (Q26740456) (← links)
- Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis (Q26774863) (← links)
- Pathophysiological Relationship between Infections and Systemic Vasculitis (Q26799915) (← links)
- Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis (Q26864089) (← links)
- Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody (Q27023640) (← links)
- The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis (Q27027790) (← links)
- Bench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivist (Q27485164) (← links)
- Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis (Q27489747) (← links)
- Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel Vasculitis (Q27490357) (← links)
- Pathophysiology of ANCA-Associated Small Vessel Vasculitis (Q28383761) (← links)
- Pathogenesis of ANCA-associated Vasculitis (Q28390438) (← links)
- The immunopathology of ANCA-associated vasculitis (Q28391531) (← links)
- Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system (Q28732877) (← links)
- Netting neutrophils in autoimmune small-vessel vasculitis (Q29615432) (← links)
- Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin (Q30482362) (← links)
- Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions (Q33372911) (← links)
- Review: Complement and its regulatory proteins in kidney diseases (Q33647738) (← links)
- Management of ANCA-associated vasculitis: Current trends and future prospects (Q33947599) (← links)
- Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases (Q34149948) (← links)
- Pathogenesis of ANCA-associated vasculitis. (Q34296337) (← links)
- CD4 T Cells Sensitized by Vascular Smooth Muscle Induce Vasculitis, and Interferon Gamma Is Critical for the Initiation of Vascular Pathology (Q34358387) (← links)
- Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice (Q35182714) (← links)
- Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. (Q35579503) (← links)
- Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors. (Q35598518) (← links)
- B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions (Q35637396) (← links)
- Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations (Q35637406) (← links)
- Mouse models of atopic eczema critically evaluated (Q38638754) (← links)
- Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease (Q35981276) (← links)
- Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis (Q36104863) (← links)
- Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (Q36183288) (← links)
- Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management. (Q36234282) (← links)
- Pharmacological therapy for Wegener's granulomatosis. (Q36530185) (← links)
- Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides (Q36535223) (← links)
- Wegener's granulomatosis: is biologic therapy useful? (Q36535231) (← links)
- Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful? (Q36560767) (← links)
- Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. (Q36667809) (← links)
- Neutrophil serine proteases fine-tune the inflammatory response (Q36737987) (← links)
- Biological therapies: new treatment options for ANCA-associated vasculitis? (Q36764935) (← links)
- ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs (Q36802625) (← links)
- Neutrophils in animal models of autoimmune disease (Q36902110) (← links)
- Current state of biologicals in the management of systemic vasculitis. (Q36958331) (← links)
- Leukocytes in glomerular injury (Q36972471) (← links)
- Renal involvement in Wegener's granulomatosis. (Q37049170) (← links)
- Targeted biologic approaches to the treatment of systemic vasculitis (Q37052724) (← links)
- Animal models of vasculitides (Q37054970) (← links)
- Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial (Q37144563) (← links)
- An approach to the diagnosis and management of systemic vasculitis. (Q37673239) (← links)
- Role of neutrophils in systemic autoimmune diseases (Q37690382) (← links)
- Update on the use of biologics in primary systemic vasculitides (Q37754811) (← links)